Login
Navigate Fool.com
Will NVO beat
the market?

Novo Nordisk

NYSE: NVO

Community Rating: 4 Stars: Favorite

171.68 -0.31 (-0.18%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $171.99
Previous Close $171.99
Daily Range $171.36 - $172.43
52-Week Range $129.41 - $194.44
Market Cap $94.4B
P/E Ratio 0.00
Dividend (Yield) $2.26 (1.3%)
Ex-Dividend Date
Dividend Pay Date
03/21/13
04/02/13
Volume 201,547
Average Daily Volume 234,922
Current FY EPS $8.14

How do you think NVO
will perform against the market?

Top NVO Bull/Bear Pitches

 

blesto (16.36)
Submitted July 21, 2011

Alzhiemer's trials with a diabetes drug?

2 Replies Reply Report this Post
 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

Will the FDA Approve Merck's Insomnia Drug?

The advisory committee meeting is this Wednesday, but investors will have to wait until the summer to discover the Food and Drug Administration's decision.

A New Drug Sales Model

20 Top Foreign Dividend Growth Stocks And Which To Consider

Good News For Health Care Stocks

Novo Nordisk Rapidly Raising Dividend

Does the Healthcare Industry mean Stability?

Will Obesity Drugs Gain Soon?

What Does This Failure Mean for Eli Lilly Investors?

Eli Lilly announced that it will stop developing cancer drug candidate enzastaurin. What does this mean for its business?

Why This Stock's Crash is a Buying Opportunity

The Ups and Downs of Diabetes

See More NVO News...

Sector

Healthcare

Industry

Drugs

Novo Nordisk (NVO) Description

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website: http://www.novonordisk.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks